Thalidomide-induced serious RR interval prolongation (longest interval >5.0 s) in multiple myeloma patient with rectal cancer: A case report

Primary secondary tumor increased recently with the use of immunomodulatory drugs in patients with multiple myeloma (MM). However, MM with prior diagnosis of primary secondary tumor is relatively rare. In this study, we reported an MM patient with prior diagnosis of rectal cancer. In brief, an 85-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Li, Kuang, Yuemin, Jiang, Zhiyong, Zhu, Yan, Luo, Xinguo, Shi, Fangjing, Hu, Shanshan, Gao, Xinfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712095/
https://www.ncbi.nlm.nih.gov/pubmed/33336009
http://dx.doi.org/10.1515/med-2020-0136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712095/
https://www.ncbi.nlm.nih.gov/pubmed/33336009
http://dx.doi.org/10.1515/med-2020-0136

Ejemplares similares